ReviewFrontiers in immunology2023

HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma.

Chen Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.